Two Sigma Investments, LP Icosavax, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$4.89 - $10.57 $368,407 - $796,333
-75,339 Reduced 78.99%
20,034 $198,000
Q1 2023

May 15, 2023
BUY
$5.62 - $11.51 $111,894 - $229,164
19,910 Added 26.38%
95,373 $553,000
Q4 2022

Feb 14, 2023
BUY
$2.32 - $10.97 $39,050 - $184,647
16,832 Added 28.71%
75,463 $599,000
Q3 2022

Nov 14, 2022
BUY
$3.09 - $9.21 $181,169 - $539,991
58,631 New
58,631 $185,000

Others Institutions Holding ICVX

# of Institutions
2
Shares Held
1.37M
Call Options Held
0
Put Options Held
0
View Full List

About Icosavax, Inc.

ICVX Quotes by TradingView
  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email